MATCHING-ADJUSTED INDIRECT COMPARISON OF GUSELKUMAB VERSUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS: CHANGE IN BASELINE PASI FROM WEEK 4-40

被引：0
|
作者：
Sanyal, C. [1 ]
Situ, A. [2 ]
Alulis, S. [3 ]
Hassan, F. [4 ]
Peterson, S. [5 ]
Lee, J. [6 ]
机构：
[1] Eversana, Sydney, NS, Canada
[2] Sunovion Pharmaceut Canada Inc, Mississauga, ON, Canada
[3] Janssen Cilag Denmark, Birkerod, Denmark
[4] Janssen EMEA, High Wycmbe, England
[5] Janssen Immunol Global Commercial Strategy Org, Horsham, PA USA
[6] Janssen, Birkerod, Denmark
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 01期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
POSB320
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [1] Matching-adjusted indirect comparison of guselkumab versus risankizumab in patients with moderate-to-severe plaque psoriasis: Change in baseline Psoriasis Area and Severity Index from week 4 to 40
    Langley, Richard G.
    Sanyal, Chiranjeev
    Situ, Aaron
    Alulis, Sarah
    Hassan, Fareen
    Peterson, Steve
    Teneralli, Rachel E.
    Lee, Jennifer
    Patel, Barkha P.
    Disher, Tim
    [J]. JAAD INTERNATIONAL, 2024, 15 : 165 - 167
  • [2] COMPARATIVE EFFICACY OF GUSELKUMAB AND TILDRAKIZUMAB IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: A MATCHING-ADJUSTED INDIRECT COMPARISON
    Van, Sanden S.
    Diels, J.
    Schubert, A.
    Barthelmes, J.
    [J]. VALUE IN HEALTH, 2020, 23 : S410 - S410
  • [3] Matching-adjusted indirect treatment comparison of guselkumab and ixekizumab in patients with moderate-to-severe psoriasis
    Varu, Abhishek
    Cameron, Chris
    Diels, Joris
    Hutton, Brian
    McElligott, Sean
    Schubert, Agata
    van Sanden, Suzy
    Villacorta, Reggie
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB187 - AB187
  • [4] Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab
    Warren, R. B.
    Brnabic, A.
    Saure, D.
    Langley, R. G.
    See, K.
    Wu, J. J.
    Schacht, A.
    Mallbris, L.
    Nast, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2018, 178 (05) : 1064 - 1071
  • [5] Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison
    Hampton, Philip
    Borg, Emma
    Hansen, Jes Birger
    Augustin, Matthias
    [J]. PSORIASIS-TARGETS AND THERAPY, 2021, 11 : 123 - 131
  • [6] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    April W. Armstrong
    Sang Hee Park
    Vardhaman Patel
    Malcolm Hogan
    Wei-Jhih Wang
    David Davidson
    Viktor Chirikov
    [J]. Dermatology and Therapy, 2023, 13 : 2589 - 2603
  • [7] Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    Armstrong, April W.
    Park, Sang Hee
    Patel, Vardhaman
    Hogan, Malcolm
    Wang, Wei-Jhih
    Davidson, David
    Chirikov, Viktor
    [J]. DERMATOLOGY AND THERAPY, 2023, 13 (11) : 2589 - 2603
  • [8] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Christopher J. Edwards
    Ruta Sawant
    Vishvas Garg
    Ella X. Du
    Alan Friedman
    Keith A. Betts
    [J]. Rheumatology and Therapy, 2021, 8 : 167 - 181
  • [9] A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis
    Edwards, Christopher J.
    Sawant, Ruta
    Garg, Vishvas
    Du, Ella X.
    Friedman, Alan
    Betts, Keith A.
    [J]. RHEUMATOLOGY AND THERAPY, 2021, 8 (01) : 167 - 181
  • [10] Correction to: Matching-Adjusted Indirect Comparison of the Long-Term Efficacy of Deucravacitinib Versus Adalimumab for Moderate to Severe Plaque Psoriasis
    April W. Armstrong
    Sang Hee Park
    Vardhaman Patel
    Malcolm Hogan
    Wei-Jhih Wang
    David Davidson
    Viktor Chirikov
    [J]. Dermatology and Therapy, 2023, 13 : 2605 - 2607
12345